Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/1998
12/09/1998CN1201454A Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists
12/09/1998CN1201452A 24-homo-26,27-hexafluoro-choleccalciferols
12/09/1998CN1201447A Butyrate prodrugs of lactic acid
12/09/1998CN1201387A Lyophilized thioxanthenone anti-tumor angents
12/09/1998CN1201369A Stimulation of cell-mediated immune responses by targeted particulated genetic immunization
12/09/1998CN1201037A 5'-deoxy-cytidine derivatives
12/09/1998CN1041096C Fluorinated 17 beta-substituted 4-aza-5 alpha-androstane-3-one derivatives
12/09/1998CN1041094C Lobaplatin-trihydrat, its preparation method and use
12/09/1998CN1041091C Trisubstituted pyrimido (5,4-d) pyrimidines for modulating multi-medicine resistance, medicinal composition containing said compound and preparation
12/08/1998US5847119 2-bromo-and derivatives of 3-bromo-and 3,3-dibromo-4-oxo-azetidines, processes for the preparation thereof and use thereof
12/08/1998US5847114 Poly-substituted phthalocyantines
12/08/1998US5847106 Monomeric and dimeric nucleosides with silyl-containing diamino phosphorous linkages
12/08/1998US5847078 Polypeptide capable of differentiating and maturing malignant cells into normal cells or capable of accelerating the formulation of erythroblasts
12/08/1998US5847004 Method for in vivo reduction of nitric oxide levels and compositions useful therefor
12/08/1998US5847000 Fatty acid derivatives
12/08/1998US5846998 Use of phosphotyrosine phosphatase inhibitors or phosphotyrosine kinase activators for controlling cellular proliferation
12/08/1998US5846988 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
12/08/1998US5846987 Retroviral protease inhibiting compounds
12/08/1998US5846959 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
12/08/1998US5846947 Composition containing nucleic acids, preparation and uses
12/08/1998US5846827 Methods for ex vivo therapy using peptide-loaded antigen presenting cells for the activation of CTL
12/08/1998US5846826 Isolated cytolytic T cell line specific to complexes of HLA-B44 molecules and specific nonapeptides
12/08/1998US5846810 Human 26S proteasome subunit components
12/08/1998US5846800 Nucleic acid molecules encoding a novel receptor-type protein tyrosine phosphatase-σ
12/08/1998US5846741 Boron neutron capture therapy using pre-targeting methods
12/08/1998US5846725 Methods for identifying cisplatin resistant tumor cells
12/08/1998US5846712 Tumor suppressor gene, HIC-1
12/08/1998US5846548 Combined administration of mitogenic immumo stimulator and a thymomimetic
12/08/1998US5846545 Targeted delivery of cyclopropylbenzindole-containing cytotoxic drugs
12/08/1998US5846540 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments
12/08/1998CA2026671C 24-homo vitamin d derivatives, process for their production and pharmaceutical preparations obtained therefrom
12/03/1998WO1998054343A1 Anti-cancer vaccine
12/03/1998WO1998054324A1 Human multiple endocrine neoplasia type 1 protein
12/03/1998WO1998054321A1 New human dp1 homolog
12/03/1998WO1998054318A1 TUMOUR SUPPRESSOR GENE DBCCR1 AT 9q32-33
12/03/1998WO1998054316A1 Sodium channel receptor
12/03/1998WO1998054313A2 Dna methyltransferase genomic sequences and antisense oligonucleotides
12/03/1998WO1998054311A1 Zinc finger protein derivatives and methods therefor
12/03/1998WO1998054217A1 Angiostatin fragments and method of use
12/03/1998WO1998054210A1 Peptide compositions for tumor inhibition
12/03/1998WO1998054203A1 Inhibition of stress activated protein kinase (sapk) pathway and sensitization of cells to cancer therapies
12/03/1998WO1998054187A1 Spiro-azacyclic derivatives and their use as therapeutic agents
12/03/1998WO1998054185A1 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydro-pyrrolo[3,2-d]pyrimidin-4-ones
12/03/1998WO1998054180A1 Novel compounds
12/03/1998WO1998054170A1 SUBSTITUTED 2-(2,6-DIOXOPIPERIDIN-3-YL)-PHTHALIMIDES AND 1-OXOISOINDOLINES AND METHOD OF REDUCING TNFα LEVELS
12/03/1998WO1998054158A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES
12/03/1998WO1998054157A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p561ck TYROSINE KINASES
12/03/1998WO1998054156A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56lck TYROSINE KINASES
12/03/1998WO1998054147A1 Cyanoamidines as cell proliferation inhibitors
12/03/1998WO1998054146A1 Cyanoguanidines as cell proliferation inhibitors
12/03/1998WO1998054145A1 Cyanoguanidines as cell proliferation inhibitors
12/03/1998WO1998054144A1 Cyanoguanidines as cell proliferation inhibitors
12/03/1998WO1998054143A1 Cyanoguanidines as cell proliferation inhibitors
12/03/1998WO1998054141A1 Cyanoguanidines as cell proliferation inhibitors
12/03/1998WO1998054093A1 Novel angiogenesis inhibitors
12/03/1998WO1998053858A1 Ternary ligand complexes useful as radiopharmaceuticals
12/03/1998WO1998053840A1 SIALOADHESIN FAMILY 4 cDNA
12/03/1998WO1998053839A2 Anti-cancer products for treating cystic fibrosis
12/03/1998WO1998053835A1 The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer
12/03/1998WO1998053821A1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-β1
12/03/1998WO1998053811A1 Method and compositions for administering taxanes orally to human patients
12/03/1998WO1998053810A1 Pharmaceutical injection solution containing taxol
12/03/1998WO1998053801A1 Conjugated peptide nucleic acids having enhanced cellular uptake
12/03/1998WO1998045712A3 20 human secreted proteins
12/03/1998WO1998045332A3 Humanized antibodies and methods for forming humanized antibodies
12/03/1998WO1998045331A3 Anti-vegf antibodies
12/03/1998WO1998042739A3 Secreted proteins and polynucleotides encoding them
12/03/1998WO1998041631A3 β-CATENIN, TCF-4, AND APC INTERACT TO PREVENT CANCER
12/03/1998WO1998041238A3 Methods and kits for treating and diagnosing leiomyomas
12/03/1998WO1998033916A3 Secreted proteins and polynucleotides encoding them
12/03/1998DE19719652A1 Use of tissue factor
12/03/1998CA2292877A1 Cyanoguanidines as cell proliferation inhibitors
12/03/1998CA2292876A1 Cyanoguanidines as cell proliferation inhibitors
12/03/1998CA2291861A1 Zinc finger protein derivatives and methods therefor
12/03/1998CA2291839A1 Conjugated peptide nucleic acids having enhanced cellular uptake
12/03/1998CA2291774A1 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/03/1998CA2291750A1 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/03/1998CA2291728A1 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/03/1998CA2291709A1 Novel angiogenesis inhibitors
12/03/1998CA2291595A1 Dna methyltransferase genomic sequences and antisense oligonucleotides
12/03/1998CA2291489A1 Cyanoguanidines as cell proliferation inhibitors
12/03/1998CA2291451A1 Inhibition of stress activated protein kinase (sapk) pathway and sensitization of cells to cancer therapies
12/03/1998CA2291258A1 Inhibitors of naaladase enzyme activity
12/03/1998CA2291235A1 Cyanoamidines as cell proliferation inhibitors
12/03/1998CA2290954A1 Human multiple endocrine neoplasia type 1 protein
12/03/1998CA2290943A1 New human dp1 homolog
12/03/1998CA2289037A1 Spiro-azacyclic derivatives and their use as therapeutic agents
12/03/1998CA2288967A1 Selective induction of cell death by delivery of amino-terminal interleukin-1-alpha pro-piece polypeptide
12/03/1998CA2288317A1 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydro-pyrrolo¬3,2-d|pyrimidin-4-ones
12/03/1998CA2288235A1 Tumour suppressor gene dbccr1 at 9q32-33
12/03/1998CA2287974A1 Ternary ligand complexes useful as radiopharmaceuticals
12/02/1998EP0881300A2 Method for identifying compounds for inhibition of neoplastic lesions
12/02/1998EP0881298A2 Metalloporoteases
12/02/1998EP0881294A2 HOEFCC11, a HAS2 splicing variant
12/02/1998EP0881289A2 Novel 7TM receptor (H2CAA71)
12/02/1998EP0880517A1 Quinazoline compounds
12/02/1998EP0880512A1 Novel aromatic piperazines derived from substituted cycloazanes, method for preparing same, pharmaceutical compositions, and use thereof as drugs
12/02/1998EP0880507A1 Quinazoline derivatives as antitumor agents
12/02/1998EP0880499A1 Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
12/02/1998EP0880363A1 Combinations, having immunosuppressive effects, containing a cyclooxygenase-2 inhibitor and a leukotriene a 4? hydrolase inhibitor
1 ... 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 ... 2211